#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Renal cell carcinoma Ehlers-Danlos syndrome Retinal dystrophy Mastocytosis Hepato-lenticular degeneration Congenital cystic kidney disease Thymic carcinoma Neoplasm malignant Scleroderma associated digital ulcer Keratosis follicular Rhabdomyosarcoma Cluster headache Waldenstrom's macroglobulinaemia Glomerulonephritis rapidly progressive Infective uveitis More trials…

    Learn about Rare Diseases

    Osteosarcoma Chondrosarcoma – Trials in Disease Kearns-Sayre syndrome – Basic Information Nodal marginal zone B-cell lymphoma Haemophilia A with anti factor VIII – Diagnostics Combined immunodeficiency – Diagnostics Gaucher’s disease type III – Treatment Lysosomal storage disorder – Basic Information Rett syndrome – Basic Information Cystic fibrosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iti-1284 Fedratinib Tuvusertib SODIUM BENZOATE Folic Acid Doxribtimine Futibatinib Utreglutide Bleomycin Sulfate Ph. Eur. Diltiazem Sotagliflozin Enasidenib Mesilate Brimonidine AMG 732 Safinamide Vh4524184 Flecainide Acetic Acid, Glacial Abc-15Bo-116 Flecainide Acetate More therapies…

    Learn about Your Condition

    Cerebral haemorrhage Encephalitis Japanese B Chondroplasty Double hit lymphoma COVID-19 Epileptic encephalopathy Hyperhidrosis Diabetic retinal oedema Hypertension Eye pain Thyroid mass Cerebral palsy Hepatotoxicity Chronic hepatic failure Diarrhoea More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Comparing Dapagliflozin and Tocilizumab for Treating Patients with Systemic Sclerosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Dapagliflozin
    • Sodium Chloride
    • Tocilizumab
    Poland

  • A Study Testing the Accuracy of 68Ga-Pentixafor PET/CT Imaging in Patients with Cardiac Sarcoidosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac sarcoidosis
    Investigated Drugs:
    • Pentixafor
    • Gallium (68Ga)
    The Netherlands

  • A study testing landiolol in patients with ST-elevation acute coronary syndrome undergoing primary percutaneous coronary intervention

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    Investigated Drugs:
    • Landiolol Hydrochloride
    • Sodium Chloride
    Austria

  • A study testing dust mite allergy extracts from Dermatophagoides pteronyssinus and Dermatophagoides farinae for patients with allergic rhinoconjunctivitis with or without controlled asthma

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Mite allergy
    Investigated Drugs:
    • Beclometasone Dipropionate Anhydrous
    • Fluticasone Furoate
    • Budesonide
    Spain

  • A study to test if BHV-8000 is effective and safe for adults with early Parkinson’s disease

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Ioflupane (123I)
    Austria Belgium Czechia France Germany Italy +4

  • A Study Comparing Nipocalimab and Efgartigimod for Adults with Generalized Myasthenia Gravis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Efgartigimod Alfa
    • Nipocalimab
    Austria Germany Italy Spain
Previous Page
1 … 749 750 751 752 753 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!